CRI Worldwide Significantly Expands Kirkbride Division

Inpatient and Outpatient Clinical Research Services Now Housed
Together in State-of-the-Art Facility
CLEMENTON, N.J.--(Business Wire)--
CRI Worldwide, Inc., a leading provider of clinical research
services to the global pharmaceutical and biotech industry, has
announced a major expansion of its Kirkbride Division. The facility is
housed within the Kirkbride Center, an acute care psychiatric hospital
located in West Philadelphia near the University of Pennsylvania. The
newly renovated clinical research center nearly quadruples CRI's
previous space, and allows the firm to conduct both inpatient and
outpatient clinical trials, from early stage through late stage, at
one state-of-the-art facility.

"The expansion of Kirkbride allows CRI Worldwide to have some of
the greatest research scientists all working collaboratively under one
roof," said Dr. Howard Hassman, Founder and Chief Scientific Officer,
CRI Worldwide. "The expanded, modernized facility provides a superior
environment for CRI to perform Phase I-IV clinical trials - both
inpatient and outpatient - and to more effectively meet patient,
client and sponsor needs."

Kirkbride Center is the first psychiatric hospital in the US. The
expansion of CRI at Kirkbride significantly increases clinical
capacity, and features a new laboratory, exam rooms, patient consent
rooms, inpatient clinical support, conference rooms, storage areas, a
well-appointed waiting room, physicians' offices, and an atrium
garden. Six physicians, including MDs, DOs and PhDs - all with well
recognized central nervous system expertise ranging from pain to
psychiatric disorders - will serve on the staff in a full-time
capacity.

"With its outstanding access to a dense patient population,
industry leading investigators, proximity to leading clinical talent,
and recognized excellence in clinical quality, CRI's Kirkbride
Division is one of our premier research centers," said Ken King,
President and Chief Executive Officer, CRI Worldwide.

The transition to the new facility at CRI at Kirkbride Center was
completed in February 2008.

About CRI Worldwide

CRI Worldwide, Inc., with headquarters in Clementon, NJ, is a
leading provider of clinical development testing and research services
for central nervous system, psychiatric and other drug compounds. The
company conducts Phase I-IV inpatient and outpatient studies in fully
licensed and accredited acute care hospitals. Additional information
is available at www.criww.com.

For CRI Worldwide, Inc.
Barbara Link, 610-668-3433, ext. 3
pr@gmpadvertising.com

Copyright Business Wire 2008